NCT02099136View on ClinicalTrials.gov

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

September 30, 2001

Study Completion Date

December 31, 2004

Conditions
No Evidence of Disease
Interventions
PROCEDURE

UV Light Therapy

Undergo UV-irradiation

OTHER

Placebo

Given PO

DRUG

Celecoxib

Given PO

PROCEDURE

Biopsy

Undergo skin biopsy

OTHER

Imaging Biomarker Analysis

Correlative studies

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02099136 - Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers | Biotech Hunter | Biotech Hunter